Analyst InsightsBiotech StocksStock News Why Analysts See Solid Upside Potential for Ocular Therapeutix (OCUL), Catalyst Pharmaceuticals (CPRX), and AcelRx (ACRX) Ocular Therapeutix (OCUL), Catalyst Pharmaceuticals (CPRX) and AcelRx Pharmaceuticals (ACRX) look forward to important regulatory approval decisions this year. Could these catalysts give these small … Jason Cohen, October 10, 2018
Analyst InsightsBiotech StocksStock News Cantor Sees Strong Upside in Catalyst Pharmaceuticals (CPRX) Shares, Sets an $8 Price Target Many investors hope to win big on biotech stocks as shares can skyrocket when there is good news. With that in mind, Cantor … Jason Cohen, September 20, 2018
Hedge-Fund NewsStock News Healthcare Wiz Mitchell Blutt Bets Big on These 3 Biotech Stocks Hedge fund manager Mitchell J. Blutt of the $1. Smarter Team, August 30, 2018
Biotech StocksLong IdeasStock News Why Catalyst Pharmaceuticals (CPRX) Is a $6 Stock Investors in Catalyst Pharmaceuticals (NASDAQ:CPRX) have been waiting for two-and-a-half years since its marketing application was originally submitted to see the company’s flagship candidate … Jason Cohen, August 22, 2018
Biotech StocksInsights Catalyst Pharmaceuticals Inc (CPRX) Shakes Hands with FDA on SPA for Firdapse; SunTrust Chimes In Though NDA Gets Stalled, Analyst Says Catalyst “Still on Track” Joe Rabin, Editor, September 1, 2017
Biotech StocksStock News Stock Update (NASDAQ:CPRX): Catalyst Pharmaceuticals Inc Announces First Patient Enrolled in Second Phase 3 Trial of Firdapse in LEMS Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) announced that the first patient has been enrolled into its second Phase 3 clinical trial (designated as LMS-003) to … Corey Williams, December 15, 2016
Biotech StocksStock News Stock Update (NASDAQ:CPRX): Here’s Why Catalyst Pharmaceuticals Inc Shares Are Rising 16% Today Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) investors have a smile on their faces Thursday morning, after the small biotech company provided an update on its clinical … Corey Williams, December 8, 2016
Biotech StocksStock News Company Update (NASDAQ:CPRX): Here’s Why Catalyst Pharmaceuticals Inc Shares Are Rising 14% Today Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) investors cheer the news that the biopharmaceutical company has reached an agreement with the FDA under a Special Protocol Assessment (SPA) for … Corey Williams, October 31, 2016
Biotech StocksInsights Roth Capital Weighs in on Catalyst Pharmaceuticals Inc (CPRX) Following Meeting with Management Roth Capital analyst Scott Henry is out today with a research note on shares of Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), following recent meeting with the company’s senior management. … Jason Cohen, October 13, 2016
Biotech StocksStock News Company Update (NASDAQ:CPRX): Here’s Why Catalyst Pharmaceuticals Inc Shares Are Up 25% Today Investors in Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) are having a great day. Shares of the biotech are up nearly 25% in the wake of analyst upgrade. Corey Williams, October 5, 2016
